Looks like you’re on the UK site. Choose another location to see content specific to your location
Pentax Medical announces takeover of C2 Therapeutics
Pentax Medical has agreed a deal to purchase C2 Therapeutics, a medical technology company based in California.
The move will significantly strengthen Pentax's capabilities in the field of therapeutic endoscopy, allowing the company to provide treatment options for gastroenterology applications in addition to its current diagnostic imaging products.
C2's product range include the C2 CryoBalloon ablation system, designed for the endoscopic ablation of unwanted tissue associated with conditions such as Barrett’s oesophagus and squamous dysplasia.
Using this system, interventional endoscopists can deliver a targeted dose of cryogen to ablate these tissues immediately, meaning patients are less likely to see their conditions progress into oesophageal cancer.
Following the takeover, Pentax will work with thought leaders from around the world to further develop the C2 CryoBalloon system and commercialise the technology worldwide.
David Woods, global chief marketing officer at Pentax Medical, said: "Our investment in C2 Therapeutics is continued evidence of our commitment to bring best-in-class imaging, along with cutting-edge technology that helps the therapeutic endoscopist access, visualise and treat disease."
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard